Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 6
1984 5
1985 6
1986 5
1987 7
1988 4
1989 13
1990 10
1991 13
1992 8
1993 11
1994 17
1995 9
1996 13
1997 8
1998 7
1999 7
2000 7
2001 9
2002 9
2003 12
2004 9
2005 13
2006 15
2007 23
2008 14
2009 17
2010 15
2011 13
2012 12
2013 25
2014 12
2015 11
2016 11
2017 16
2018 12
2019 14
2020 9
2021 10
2022 6
2023 4
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Results by year

Filters applied: . Clear all
Page 1
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal.
Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ, Franssen FME, Humbert M, Hurst JR, O'Donnell D, Pantoni L, Papi A, Rodriguez-Roisin R, Sethi S, Torres A, Vogelmeier CF, Wedzicha JA. Celli BR, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP. Am J Respir Crit Care Med. 2021. PMID: 34570991 Free article. No abstract available.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Vestbo J, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.
COPD and multimorbidity: recognising and addressing a syndemic occurrence.
Fabbri LM, Celli BR, Agustí A, Criner GJ, Dransfield MT, Divo M, Krishnan JK, Lahousse L, Montes de Oca M, Salvi SS, Stolz D, Vanfleteren LEGW, Vogelmeier CF. Fabbri LM, et al. Lancet Respir Med. 2023 Nov;11(11):1020-1034. doi: 10.1016/S2213-2600(23)00261-8. Epub 2023 Sep 8. Lancet Respir Med. 2023. PMID: 37696283 Review.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Vogelmeier CF, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP. Am J Respir Crit Care Med. 2017. PMID: 28128970 Free article.
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice.
Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook RD, Criner GJ, Franssen FME, Humbert M, Hurst JR, Montes de Oca M, Pantoni L, Papi A, Rodriguez-Roisin R, Sethi S, Stolz D, Torres A, Vogelmeier CF, Wedzicha JA. Celli BR, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2023 May 1;207(9):1134-1144. doi: 10.1164/rccm.202209-1795CI. Am J Respir Crit Care Med. 2023. PMID: 36701677 Free PMC article. Review.
Management of chronic refractory cough in adults.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A. Visca D, et al. Among authors: fabbri lm. Eur J Intern Med. 2020 Nov;81:15-21. doi: 10.1016/j.ejim.2020.09.008. Epub 2020 Sep 19. Eur J Intern Med. 2020. PMID: 32958373 Free PMC article. Review.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.
Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C. Ferguson GT, et al. Among authors: fabbri lm. Lancet Respir Med. 2018 Oct;6(10):747-758. doi: 10.1016/S2213-2600(18)30327-8. Epub 2018 Sep 16. Lancet Respir Med. 2018. PMID: 30232048 Clinical Trial.
Response.
Vanfleteren LEGW, Fabbri LM. Vanfleteren LEGW, et al. Among authors: fabbri lm. Chest. 2020 Feb;157(2):475-476. doi: 10.1016/j.chest.2019.10.020. Chest. 2020. PMID: 32033653 No abstract available.
The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study.
Kraft M, Richardson M, Hallmark B, Billheimer D, Van den Berge M, Fabbri LM, Van der Molen T, Nicolini G, Papi A, Rabe KF, Singh D, Brightling C, Siddiqui S; ATLANTIS study group. Kraft M, et al. Among authors: fabbri lm. Lancet Respir Med. 2022 Jul;10(7):661-668. doi: 10.1016/S2213-2600(21)00536-1. Epub 2022 Mar 2. Lancet Respir Med. 2022. PMID: 35247313
431 results